Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMichael A. Harding, Dan Theodorescu
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer metastasis
10.1093/oxfordjournals.bmb.a072453 · 1991
Critical determinants of cancer metastasis
10.1007/s002800051091 · 1999
American Society for Therapeutic Radiology and Oncology Consensus Panel
1997
Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer
10.1016/s0090-4295(98)00153-8 · 1998
Therapeutic radiation in patients with a rising post-prostatectomy PSA level
1998
Prognostic markers in localized prostate cancer
10.1023/a:1006137721823 · 1998
Prostate cancer
1997
Diagnostic and prognostic markers for human prostate cancer
10.1002/(sici)1097-0045(19970601)31:4<264::aid-pros8>3.0.co;2-k · 1997
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
The multistep nature of cancer
10.1016/0168-9525(93)90209-z · 1993
Mechanisms of tumor progression
1986
Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread
10.1002/ijc.2910470121 · 1991
Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo
10.1002/jcp.1041480308 · 1991
Neuroendocrine differentiation in prostatic carcinoma
10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · 1999
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors
10.1002/(sici)1097-0045(1998)8+<43::aid-pros8>3.0.co;2-h · 1998
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate
10.1002/(sici)1097-0142(19971201)80:11<2109::aid-cncr10>3.0.co;2-2 · 1997
Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
10.1002/(sici)1097-0045(1998)8+<37::aid-pros7>3.0.co;2-d · 1998
Neuroendocrine differentiation in prostate cancer
10.1016/s0046-8177(96)90398-6 · 1996
Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
10.1038/bjc.1996.456 · 1996
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible
1999
Tumor dormancy in vivo by prevention of neovascularization
10.1084/jem.136.2.261 · 1972
Metastasis and angiogenesis
10.3109/02841869009089997 · 1990
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
10.1038/sj.onc.1200977 · 1997
Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer
10.1016/0046-8177(95)90122-1 · 1995
Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma
10.1006/exer.1996.0141 · 1996
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
10.1016/s0090-4295(96)00149-5 · 1996
Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia
1995
Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
10.1002/1097-0142(19940201)73:3<678::aid-cncr2820730329>3.0.co;2-6 · 1994
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
10.1097/00005392-199707000-00040 · 1997
Microvessel density, p53, retinoblastoma, and chromogranin a immunohistochemistry as predictors of disease-specific survivial following radical prostatectomy for carcinoma of the prostate
10.1016/s0090-4295(99)00598-1 · 2000
Tumor induction of VEGF promoter activity in stromal cells
10.1016/s0092-8674(00)81731-6 · 1998
Quantitative angiogenesis assays
10.1038/nm1197-1203 · 1997
Fractal characteristics of tumor vascular architecture during tumor growth and regression
10.3109/10739689709146803 · 1997
Role of tumor vascular architecture in nutrient and drug delivery
10.1006/mvre.1996.0031 · 1996
Targeting gene expression to hypoxic tumor cells
10.1038/nm0597-515 · 1997
Morphology of prostate cancer
10.1016/s0022-5347(17)32368-6 · 1994
Clinical relevance of the individual prostate cancer focus
10.3109/07357909409038236 · 1994
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors
10.1002/1097-0142(19921101)70:9<2313::aid-cncr2820700917>3.0.co;2-t · 1992
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications
10.1002/(sici)1096-9896(199611)180:3<295::aid-path663>3.0.co;2-w · 1996
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
10.1016/s0090-4295(99)00167-3 · doi-reference
Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction
10.1016/s0022-5347(01)61592-1 · doi-reference
Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer
10.1038/bjc.1997.114 · doi-reference
Identification of bone marrow micrometastases in patients with prostate cancer
10.1002/1097-0142(19941101)74:9<2533::aid-cncr2820740922>3.0.co;2-d · doi-reference
Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate
10.1002/mc.2940070307 · doi-reference
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
10.1016/0092-8674(89)90625-9 · doi-reference
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate
10.1210/mend-5-4-503 · doi-reference
Aneuploidy index in blood
10.1016/s0090-4295(98)00487-7 · doi-reference
Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization
10.1007/s004280050252 · doi-reference
Independent origin of multiple foci of prostatic intraepithelial neoplasia
10.1002/(sici)1097-0142(19981101)83:9<1995::aid-cncr16>3.0.co;2-2 · doi-reference